{
    "2021-06-11": [
        [
            {
                "time": "",
                "original_text": "刘玉(广发基金)投资风格分析：深耕“核心-卫星”组合框架追求长期稳健投资回报",
                "features": {
                    "keywords": [
                        "广发基金",
                        "核心-卫星",
                        "组合框架",
                        "长期稳健",
                        "投资回报"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "长春高新：控股子公司百克生物上市后仍纳入公司并表范围",
                "features": {
                    "keywords": [
                        "长春高新",
                        "百克生物",
                        "上市",
                        "并表范围"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "百克生物IPO：靠水痘疫苗独撑业绩？",
                "features": {
                    "keywords": [
                        "百克生物",
                        "IPO",
                        "水痘疫苗",
                        "业绩"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "45股遭北向资金减持超5000万元 减持股份数量",
                "features": {
                    "keywords": [
                        "北向资金",
                        "减持",
                        "股份数量"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "百元股数量达163只，一日增加5只",
                "features": {
                    "keywords": [
                        "百元股",
                        "数量增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}